These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 204997)
1. Prostaglandin E1 inhibitis platelet aggregation by a pathway independent of adenosine 3',5'-monophosphate. Sinha AK; Colman RW Science; 1978 Apr; 200(4338):202-3. PubMed ID: 204997 [TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP independent inhibition of platelet aggregation by prostaglandin E1 is mediated through factor Xa. Sinha AK; Colman RW Thromb Res; 1983 Jun; 30(6):553-64. PubMed ID: 6310817 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
5. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets. Salzman EW Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670 [TBL] [Abstract][Full Text] [Related]
6. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets. Ryo R Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445 [No Abstract] [Full Text] [Related]
7. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. Matthews JS; Jones RL Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586 [TBL] [Abstract][Full Text] [Related]
8. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets. Zahavi M; Zahavi J; Kakkar VV Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838 [TBL] [Abstract][Full Text] [Related]
9. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man]. Ardelt W Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100 [TBL] [Abstract][Full Text] [Related]
10. Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions. Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M; Kawasaki A; Okegawa T; Tsuboshima M Thromb Res; 1980 Dec 1-15; 20(5-6):573-80. PubMed ID: 7233385 [No Abstract] [Full Text] [Related]
11. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change. Steen VM; Holmsen H Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615 [TBL] [Abstract][Full Text] [Related]
12. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi M; Zahavi J; Kakkar VV Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048 [TBL] [Abstract][Full Text] [Related]
13. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Haslam RJ; Rosson GM Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501 [No Abstract] [Full Text] [Related]
14. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP. Akbar H; Navran SS; Chang J; Miller DD; Feller DR Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114 [TBL] [Abstract][Full Text] [Related]
15. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets. Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342 [TBL] [Abstract][Full Text] [Related]
16. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets. Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045 [No Abstract] [Full Text] [Related]
17. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038 [TBL] [Abstract][Full Text] [Related]
18. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373 [TBL] [Abstract][Full Text] [Related]
19. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function. Claesson HE; Malmsten C Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812 [TBL] [Abstract][Full Text] [Related]
20. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 . Boullin DJ; Green AR; Price KS J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]